Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α

Cancer Research

Volumn 56, Issue 4, 1996, Pages 866-874

  Geng, Yong Jian ^a,b,c   Hellstrand, Kristoffer ^b   Wennmalm, Åke ^b   Hansson, Göran K ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; HOST RESISTANCE; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; TUMOR IMMUNOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; APOPTOSIS; ARGININE; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA, NEOPLASM; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA, RECOMBINANT; ISOENZYMES; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MITOCHONDRIA; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030039911     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hibbs, J. J. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity Res. Immunol., 142. 565-569, 1991.
2. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J., 6: 3051-3064, 1992.
3. Stuehr, D. J, and Nathan, C. F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor cells. J. Exp. Med., 169 1543-1545, 1989
4. Drapier, J-C , and Hibbs, J. B. J. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. J. Clin Invest., 78: 790-797, 1986.
5. Lepoivre, M., Chenais, B., Yapo, A , Lemaire, G., Thelander, L., and Tenu, J-P Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells J. Biol Chem., 265. 4143-4149, 1990.
6. Lepoivre, M , Fieschi, F., Coves, J , Thelander, L., and Fontecave, M. Inactivation of ribonucleotide reductase by macrophage-derived nitric oxide. Biochem. Biophys. Res Commun., 179: 442-448, 1991.
7. Kwon, N. S , Stuehr, D. J., and Nathan, C. F. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med., 174: 761-767, 1991.
8. Sarih, M., Souvannavong, V., and Adam, A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res Commun., 191: 503-508, 1993
9. Albina, J E., Cui, S., Mateo, R B., and Reichner, J. S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages J Immunol., 150: 5080-5085, 1993.
10. Cui, S., Reichner, J. S., Mateo, R. B., and Albina, J. E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res , 54: 2462-2467, 1994.
11. Xie, K., Huang, S., Dong, Z., Huang, S-H., Gutman, M., Xie, Q-w., Nathan, C., and Fidler, I. J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 181: 1333-1343, 1995.
12. Moncada, S., and Higgs, A. The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329: 2002-2012, 1993.
13. Cho, H. J., Xie, Q. W , Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., and Nathan, C. Calmodulin is a subunit of nitric oxide synthase from macrophages. J. Exp. Med., 176: 599-604, 1992.
14. Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H , and Russell, S W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing Molecular basis for the synergy between interferon-γ and lipopolysaccharide. J Biol. Chem., 268: 1908-1913, 1993
15. Geng, Y. J., Almqvist, M., and Hansson, G. K. cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells Biochim. Biophys. Acta, 1218: 421-424, 1994.
16. Folkman, J , and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
17. Folkman, J., and Ingber, D. Inhibition of angiogenesis. Semin. Cancer Biol., 3: 89-96, 1992.
18. Libby, P., and Hansson, G K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest., 64: 5-15, 1991.
19. Hansson, G. K. Immune and inflammatory mechanisms in the development of atherosclerosis. Br. Heart J., 69: 38-41, 1993.
20. Libby, P., and Clinton, S. K. Cytokines as mediators of vascular pathology. Nouv. Rev Fr. Hematol , 34. S47-S53, 1992.
21. Busse, R., and Mulsch. A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275: 87-90, 1990.
22. Gross, S. S., and Levi, R Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem., 267. 25722-25729, 1992.
23. Geng, Y., Hansson, G. K , and Holme, E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res., 71: 1268-1276, 1992.
24. Geng, Y. J., Wu, Q., and Hansson, G. K. Protein kinase C activation inhibits cytokine-induced nitric oxide synthesis in vascular smooth muscle cells Biochim. Biophys. Acta, 1223: 125-132, 1994.
25. Geng, Y. J., Petersson, A S., Wennmalm, A., and Hansson, G. K. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp. Cell. Res., 214. 418-428, 1994.
26. Li, L., Nicolson, G. L., and Fidler, I. J. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res., 51: 245-254, 1991
27. Li, L., Kilbourn, R. G., Adams, J., and Fidler, I. J. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res., 51: 2531-2535, 1991.
28. Hansson, G K., Jonasson, L., Holm, J., Clowes, M. M., and Clowes, A W. γ-interferon regulates vascular smooth muscle cell proliferation and Ia antigen expression in vivo and in vitro. Circ. Res., 63: 712-719, 1988.
29. Hansson, G. K , Hellstrand, M , Rymo, L., Rubbia L., and Gabbiani, G. Interferon-γ inhibits proliferation and expression of differentiation-specific α-smooth muscle actin in arterial smooth muscle cells. J. Exp Med., 170: 1595-1608, 1989.
30. Taraboletti, G., Belotti, D., Dejana, E., Mantovani, A., and Giavazzi, R Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine gendothelioma cells transformed by polyoma virus middle T oncogene. Cancer Res., 53. 3812-3816, 1993.
31. Lozzio, C. B., and Lozzio, B. B Human chronic myelogeneous leukemia cell line with positive Philadelphia chromosome. Blood, 45: 321-324, 1975
32. Chomczynski, P., and Sacchi, N Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-160, 1987.
33. Jia, L., Jiang, X-R , Razak, K., Wu, Y-L , Newland, A. C., and Kelsey, S M. TNF-mediated killing of human leukemic cells: effects of endogenous antioxidant levels and TNF-α expression in leukemic cell lines Leukemia. Res., 19: 187-194, 1995
34. Henry, Y., Ducrocq, C., Drapier, J. C , Servent, D., Pellat C., and Guissani, A. Nitric oxide, a biological effector Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells Eur. Biophys J., 20. 1-15, 1991.
35. Henry, Y., Lepoivre, M., Drapier, J C , Ducrocq, C , Boucher, J L., and Guissani, A EPR charactenzation of molecular targets for NO in mammalian cells and organelles FASEB J., 7: 1124-1134, 1993.
36. Drapier, J. C., Pellat, C., and Henry, Y. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages. J. Biol Chem., 266: 10162-10167, 1991.
37. Lancaster, J. J , and Hibbs, J. J EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad. Sci. U S A., 87: 1223-1227, 1990
38. Lancaster, J. J , Langrehr, J. M., Bergonia, H A., Murase, N , Simmons, R. L., and Hoffman, R A. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J. Biol. Chem., 267 10994-10998, 1992.
39. Farrar, M. A., and Schreiber, R. D. The molecular cell biology of interferon-γ and its receptor. Annu Rev. Immunol., 11: 571-611, 1993.
40. Nunokawa, Y., Ishida, N., and Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells Biochem. Biophys. Res. Commun., 191: 89-94, 1993.
41. Bastian, N. R., Yim, C-Y., Hibbs, J. B , and Samlowski, W. E. Induction of iron-derived EPR signals in murine cancers by nitric oxide Evidence for multiple intracellular targets. J. Biol. Chem., 269: 5127-5131, 1994.
42. Skinner, M., and Marbrook, I. The most efficient cytotoxic T lymphocytes are the least susceptible to lysis. J. Immunol., 139. 985-987, 1987.
43. Paul, R. J. Smooth muscle energetics. Annu. Rev. Physiol., 51: 331-349, 1989.
44. Wolvetang, E. J., Johnson, K. L., Krauer, K., Ralph, S J., and Linnane, A. W. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett , 229: 40-44, 1994.
45. 125I-iodo-2′-deoxyuridine. J. Natl. Cancer Inst., 45: 773-782, 1970.
46. Fidler, I. J. Critical factors in the biology of human cancer metastasis: Twenty-eighth G. H. A. Clowes Memorial Award lecture. Cancer Res , 50: 6130-6138, 1990.
47. Gelin, J., Moldawer, L. L., Lönnroth, C , Sherry, B., Chizzonite, R., and Lundholm, K. Role of endogenous tumor necrosis factor-α and interleukin 1 for experimental tumor growth and the development of cancer cachexia Cancer Res., 51: 415-421, 1991.
48. Hansson, G. K., Geng, Y. J., Holm, J., Hårdhammar, P. Wennmalm, Å., and Jennische, E. Vascular smooth muscle cells express the inducible isoform of nitric oxide synthase during the response to endothelial injury. J. Exp Med., 180: 733-738, 1994.